artesunic acid has been researched along with Osteogenic Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, Y; Jiang, W; Wang, JP; Yu, XY; Zhang, LY | 1 |
Cheng, RL; Li, WX; Li, ZX; Peng, HQ; Sun, ZW; Xu, Q; Ye, ZM | 1 |
2 other study(ies) available for artesunic acid and Osteogenic Sarcoma
Article | Year |
---|---|
The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo.
Topics: Animals; Antimalarials; Antioxidants; Apoptosis; Artemisinins; Artesunate; Bone Neoplasms; Caspases; Cell Movement; Cell Proliferation; Disulfides; Drug Synergism; Female; Flow Cytometry; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Sulfinic Acids; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2013 |
Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Osteosarcoma; Signal Transduction; Survivin; Xenograft Model Antitumor Assays | 2011 |